NCT06304038

Cost-consequence Analysis of Influenza Vaccination in a Teaching Hospital in Rome

Cost-consequence Analysis of Influenza Vaccination Among the Staff of a Large Teaching Hospital in Rome, Italy: A Pilot Study

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 5,483 (actual)
• Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

Flu vaccination, as well as being effective to prevent seasonal influenza, decreases staff illness and absenteeism and reduces costs resulting from loss of productivity. Despite the effectiveness of flu vaccination, the seasonal coverage among healthcare workers is usually low. The aim of this retrospective observational study is to analyze the vaccination coverage rate among all employees (healthcare workers and administrative staff) of a large teaching hospital in Rome during the 2017-2018 influenza season, to perform a cost-consequence analysis of influenza vaccination (by evaluating the absenteeism due to illness in the epidemic period), and to assess the impact of vaccination in terms of both costs and sick days.

Conditions

• Influenza Vaccine
• Cost-Benefit Analysis

Interventions

Type	Name	Description
DRUG	Flu Vaccine	Administration of quadrivalent split inactivated non-adjuvanted flu vaccine Fluarix Tetra

Timeline

• Start date: 2017-10-16
• Primary completion: 2018-04-29
• Completion: 2019-11-14
• First posted: 2024-03-12
• Last updated: 2024-03-12

Locations

1 site across 1 country: Italy